OMass Therapeutics

About OMass Therapeutics

OMass Therapeutics is a pioneering biotechnology company based in the UK, dedicated to transforming the landscape of drug discovery and development. Our core mission is to harness the power of mass spectrometry to unlock the potential of complex biological systems, enabling the identification and optimisation of novel therapeutics.

At OMass, we focus on the development of innovative medicines that address unmet medical needs across various therapeutic areas, including oncology, immunology, and rare diseases. Our proprietary technology platform allows us to analyse and characterise protein complexes with unprecedented precision, facilitating the discovery of new drug candidates.

We pride ourselves on our collaborative approach, working closely with academic institutions and industry partners to advance our research and development efforts. Our team comprises highly skilled scientists and industry veterans who are passionate about pushing the boundaries of science to improve patient outcomes.

As we continue to grow, we remain committed to our core values of integrity, innovation, and excellence. We believe that by fostering a culture of creativity and collaboration, we can drive significant advancements in the field of therapeutics.

OMass Therapeutics is not just about developing drugs; it’s about making a meaningful impact on patients’ lives. We are excited about the future and the possibilities that lie ahead as we strive to bring our groundbreaking therapies to market.

• Founded: 2018
• Headquarters: Oxford, UK
• Focus Areas: Oncology, Immunology, Rare Diseases